文章图片
肖亮博士
LiangXiao,Ph.D
宜联生物
MediLinkTherapeutics
联合创始人
Co-founder
Dr.LiangXiao,cofounderofMediLinkTherapeutics(Suzhou)andhasservedasthecompany'schiefoperatingofficersinceMarch2021.Heismainlyresponsibleforantibodydiscovery,ADCevaluationandscreening,CMCandpreclinicalevaluation.
Dr.Xiaohas16yearsofexperienceinbiopharmaceuticalresearchinacademiaandindustry.Hehasbeenresponsibleforthediscovery,CMCandpreclinicalresearchofmultipleinnovativeantibodydrugs(includingmAbs,BsAbsandADCs).Amongthem,themostadvancedprogramhasfileBLAinChina,2ADCprogramsareunderPhIIIclinicaltrialsand2ADCprogramsareinPhIclinicaltrialsnow.Notably,multipleADCprogramshavereachedgloballicenseagreementwithMNC.
Dr.Xiaoreceivedhisbachelor'sdegreeinlifesciencefromtheUniversityofScienceandTechnologyofChinain2007andhisdoctor'sdegreeinchemicalengineeringfromtheUniversityofSouthernCaliforniain2013.
文章图片
吴晓东博士
EricWu,Ph.D,MBA
鑫康合生物医药
KanovaBiopharma
商务运营副总裁
VicePresidentofBussinessDevelopment&Operations
17yearsofmedicalresearchandbusinessdevelopmentexperience.
DeepknowledgeofbothUSandChinahealthcareindustries.
DirectorofbusinessdevelopmentatReistoneBiopharma.
InternationalbusinessdevelopmentmanageratQilu-Pharma.
Ph.D.fromTexasA&MUniversity.
M.B.AfromNewYorkUniversity.
文章图片
陳知瑋博士
KennethChen,Ph.D,MBA
柏思荟
bioSeedin
全球商务拓展经理
GlobalBDManager
Morethan12yearsofoverseadrugresearchanddiscoveryexperienceforautoimmunedisease.PreviouslyworkedasdrugdevelopmentresearchteamleaderattheNümbergHospitalimmunologyresearchcenter,Germany.ProjectmanagerinCRO.FunderofBioxix.BDandscientificconsultantforBioPharmadigitalmarketplacestartup.
Combinemultiplesmallmolecularandantibodydrugdevelopmentexperiencesfordifferenttypesofcancerandautoimmunedisease.Pre-INDprojectmanagementforMNCintheCRO.FundingBioxixtoprovidedrugdevelopmentanalysistechnologyandbigdataanalysisplatform.BioPharmamarketplacebusinessmodelconstruction,businessdevelopmentforMNCclients,andfurtherserviceplatformsetupandpenetration.Markingagoodcombinationofdrugdiscoveryexpertisetogetherwithbusinessdevelopmentexperience.
文章图片
张艺林
PeterZhang,MBA,CFA
垦拓资本
CondenseCapital
投资总监
InvestmentDirector
Yearsofmedicalindustryexperiences,deepexpertiseinmedicalequipment,disposables,drugsandIVDmarketingandbusinessdevelopment.HaveservedsuccessivelyinAutobio,Novartis,B.BraunandFreseniusKabi.返回搜狐 , 查看更多
【周五开播 | 从JPM大会,看新的一年行业走向】责任编辑:
- 从下周起是财神送财的日子,横财大运加身,意外惊喜不断的3生肖
- 百岁老人透漏:他从来不吃的4种美食 第一种大多数人都喜欢
- 五大抗衰老新技术带来天量市场:诺华强生新基等企业已经在行动
- 从炎症到癌症需要多久?医生告诫3种炎症不能久拖,早了解
- “天天午睡”和“从不午睡”的学生,将来差距有多大?父母来看
- 焦虑症|从临床到居家,连花清瘟始终被推荐用于一线,为什么
- 阳康的人,都可能面临脱发的危险?一文揭晓答案
- ELFENLAND|体态揭秘: 明星高级感从何而来
- 猪肉|从《扁鹊见蔡桓公》看新冠
- 红茶和绿茶究竟有何不同?可从3方面分析,爱喝茶的人不妨看看!